Literature DB >> 8383579

Pathologic correlates of prognosis in lymph node-positive breast carcinomas.

F Clayton1, C L Hopkins.   

Abstract

BACKGROUND: Many pathologic features of breast carcinomas have been proposed as prognostic correlates; their interrelationships and their relative value as prognostic indicators were studied.
METHODS: A series of 399 axillary lymph node-positive infiltrating ductal breast carcinomas was studied histologically and compared with the patient prognosis.
RESULTS: Many pathologic findings fit into two groups of closely related features--those related to the extent of local spread and those related to histologic anaplasia and mitotic count. Both groups correlated with the primary tumor size. The best predictors of long-term survival were measures of the extent of axillary metastasis (the number of axillary metastases, the size of the largest metastasis, and lymph node capsular invasion), which are components of the pathologic node stage. The mitotic count, tumor grade, primary tumor stage, smooth tumor border, tumor necrosis, and multifocal primary tumors were weaker but significant survival correlates. The mitotic count and Bloom-Richardson grade best predicted the survival time of patients with node-positive disease who died. Four years after diagnosis, less than 25% of the patients who would die of breast carcinoma in the low mitotic count and Bloom-Richardson Grade 1 (well differentiated) groups already had died; more than 75% of those in the high mitotic count and Bloom-Richardson Grade 3 (poorly differentiated) groups already had died. Among patients with small tumors (< 1.8 cm in diameter), those with one micrometastasis (1-2 mm) had a worse prognosis than those with uninvolved lymph nodes of similar size.
CONCLUSION: The extent of axillary metastasis best predicted the long-term prognosis of patients with infiltrating ductal carcinoma and axillary metastases. The mitotic count and tumor grade best predicted the survival time of those who died.

Entities:  

Mesh:

Year:  1993        PMID: 8383579     DOI: 10.1002/1097-0142(19930301)71:5<1780::aid-cncr2820710512>3.0.co;2-2

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  10 in total

1.  Lymph Node Reaction to Cancer. (Immunohistochemical and Ultrastructural Study).

Authors:  Dmitry E Tsyplakov; Semion V Petrov; Roman N Kulagin
Journal:  Pathol Oncol Res       Date:  1997       Impact factor: 3.201

2.  The value of dual-time-point 18F-FDG PET/CT for identifying axillary lymph node metastasis in breast cancer patients.

Authors:  W H Choi; I R Yoo; J H O; S H Kim; S K Chung
Journal:  Br J Radiol       Date:  2010-11-16       Impact factor: 3.039

3.  Histopathologic validation of the sentinel lymph node hypothesis for breast carcinoma.

Authors:  R R Turner; D W Ollila; D L Krasne; A E Giuliano
Journal:  Ann Surg       Date:  1997-09       Impact factor: 12.969

4.  Favorable predictive value of thyroid autoimmunity in high aggressive breast cancer.

Authors:  E Fiore; E Giustarini; C Mammoli; F Fragomeni; D Campani; I Muller; A Pinchera; C Giani
Journal:  J Endocrinol Invest       Date:  2007-10       Impact factor: 4.256

Review 5.  Prognostic value of proliferation in invasive breast cancer: a review.

Authors:  P J van Diest; E van der Wall; J P A Baak
Journal:  J Clin Pathol       Date:  2004-07       Impact factor: 3.411

6.  Assessment of Mitotic Activity in Pituitary Adenomas and Carcinomas.

Authors:  Kamal Thapar; Yukio Yamada; Bernd Scheithauer; Kalman Kovacs; Shozo Yamada; Lucia Stefaneanu
Journal:  Endocr Pathol       Date:  1996       Impact factor: 3.943

7.  Prognosis and Chemotherapy Use in Breast Cancer Patients with Multiple Lymphatic Micrometastases: An NCDB Analysis.

Authors:  Roi Weiser; Efstathia Polychronopoulou; Waqar Haque; Sandra S Hatch; Jing He; Suimin Qiu; Avi Markowitz; William J Gradishar; Yong-Fang Kuo; V Suzanne Klimberg
Journal:  Ann Surg Oncol       Date:  2021-07-11       Impact factor: 5.344

8.  Pelvic lymph node dissection in the context of radical cystectomy: a thorough insight into the connection between patient, surgeon, pathologist and treating institution.

Authors:  Roland Seiler; George N Thalmann; Pascal Zehnder
Journal:  Res Rep Urol       Date:  2013-08-12

9.  Development and characterization of a preclinical model of breast cancer lung micrometastatic to macrometastatic progression.

Authors:  Lora C Bailey-Downs; Jessica E Thorpe; Bryan C Disch; Anja Bastian; Paul J Hauser; Taleah Farasyn; William L Berry; Robert E Hurst; Michael A Ihnat
Journal:  PLoS One       Date:  2014-05-30       Impact factor: 3.240

10.  The Significance of Extent of Extracapsular Extension in Patients with T1-2 and N1 Breast Cancer.

Authors:  Gül Kanyılmaz; Sıddıka Fındık; Berrin Benli Yavuz; Meryem Aktan
Journal:  Eur J Breast Health       Date:  2018-10-01
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.